Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023
Tue, October 10, 2023
Mon, October 9, 2023

Leland Gershell Downgraded (ALNY) to Hold on, Oct 11th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ll-downgraded-alny-to-hold-on-oct-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold on, Oct 11th, 2023.

Leland has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Leland's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $175 on, Tuesday, October 10th, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023


These are the ratings of the 6 analyists that currently disagree with Leland


  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $233 on, Tuesday, October 10th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $234 on, Tuesday, October 10th, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $200 on, Monday, October 9th, 2023
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $208 on, Friday, September 29th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023